Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZR4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,593
Award facts
- Contract value 100% obligated
- $65,593.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,593.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Wegovy 1 mg/0.5 mL pens (0.5 mL dosage units). The contract is classified as a non-set-aside competitive award with an ultimate completion date of January 12, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to deliver a broad range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the AmerisourceBergen brand), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The parent company holds an additional IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, and competes on a full and open basis for federal contracts. This contract award reflects the contractor's established capability to efficiently fulfill government pharmaceutical requirements across multiple therapeutic domains, including specialty medications and brand-name drugs essential for military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F0ZR4?
SPE2DR26F0ZR4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F0ZR4 worth?
The government has obligated $65,593 on SPE2DR26F0ZR4.
Is contract SPE2DR26F0ZR4 an order under another contract?
Yes. SPE2DR26F0ZR4 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZR4 competed?
The extent of competition for SPE2DR26F0ZR4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award